Viewing Study NCT05134532


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-25 @ 7:17 PM
Study NCT ID: NCT05134532
Status: UNKNOWN
Last Update Posted: 2023-04-26
First Post: 2021-11-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC
Sponsor: CHA University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module